Intravenous Lidocaine to Reduce ED50 for Propofol Administered Using Target Controlled Infusion (TCI) During Gastroscopy
Status:
Recruiting
Trial end date:
2024-08-31
Target enrollment:
Participant gender:
Summary
The goal of this prospective, interventionnal clinical trial is to assess if intravenous
administration of linisol reduce the ED50 of propofol when administered using Target
Controlled Infusion (TCI) during gastroscopy in healthy patients (ASA 1 and 2 patients).
Prior to propofol sedation, participants will receive either an intravenous bolus of linisol
(1.5 mg/kg) = treated group or placebo = control group.